Chronic Lymphocytic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1447
|
291
|
0.640 |
None |
1.000 |
5 |
2
|
2013 |
2018 |
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 10
|
disease |
|
Finding
|
1
|
9
|
0.600 |
None |
1.000 |
2 |
9
|
2014 |
2014 |
melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3087
|
515
|
0.470 |
None |
0.857 |
7 |
2
|
2011 |
2019 |
Small Lymphocytic Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
120
|
122
|
0.400 |
None |
1.000 |
2 |
1
|
2013 |
2014 |
GLIOMA SUSCEPTIBILITY 9
|
disease |
|
Finding
|
1
|
2
|
0.400 |
None |
1.000 |
1 |
2
|
2015 |
2015 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
3097
|
353
|
0.350 |
None |
1.000 |
5 |
|
2015 |
2020 |
Malignant neoplasm of skin
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
508
|
38
|
0.310 |
None |
1.000 |
2 |
|
2011 |
2014 |
oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
282
|
21
|
0.310 |
None |
1.000 |
1 |
|
2015 |
2015 |
Lymphoid leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
288
|
4
|
0.300 |
None |
1.000 |
2 |
|
2013 |
2014 |
Familial Atypical Mole Melanoma Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
30
|
3
|
0.300 |
None |
1.000 |
2 |
|
2014 |
2014 |
Skin Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
363
|
9
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Chromosome Aberrations
|
group |
Pathological Conditions, Signs and Symptoms
|
Cell or Molecular Dysfunction
|
16
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
B-CELL MALIGNANCY, LOW-GRADE
|
disease |
|
Neoplastic Process
|
350
|
19
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Anaplastic Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
66
|
7
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Autosome Abnormalities
|
group |
Pathological Conditions, Signs and Symptoms
|
Cell or Molecular Dysfunction
|
16
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Autosomal Chromosome Disorders
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome; Congenital Abnormality
|
1
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Congenital chromosomal disease
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
757
|
47
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
mixed gliomas
|
disease |
Neoplasms
|
Neoplastic Process
|
76
|
|
0.300 |
None |
|
0 |
|
|
|
Malignant Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
724
|
22
|
0.300 |
None |
|
0 |
|
|
|
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.110 |
None |
1.000 |
1 |
|
2012 |
2012 |
CUI: |
C0027960 |
Disease: |
Nevus
|
Nevus
|
disease |
Neoplasms
|
Neoplastic Process
|
125
|
43
|
0.110 |
None |
1.000 |
1 |
|
2019 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.917 |
12 |
|
2004 |
2019 |
Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2084
|
288
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.100 |
None |
|
0 |
|
|
|
Retinopathy, CTCAE
|
phenotype |
|
Finding
|
108
|
|
0.100 |
None |
|
0 |
|
|
|